Considering that no association could be detected between the IL‐10 rs1800896 allele or genotype frequency and CML risk, a recent study indicated that IL‐10 could be a useful survival biomarker in CML.13 This evidence concerns the gene IL10 and chronic myelogenous leukemia, BCR-ABL1 positive.